.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Colorcon
Farmers Insurance
Baxter
US Department of Justice
Cipla
Express Scripts
Julphar
Queensland Health
Federal Trade Commission

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Cream
Abstract:An oil-in-water type cream comprising (a) 0.01 to 0.5% by weight of hydrocortisone butyrate proponate, (b) 5 to 50% by weight of a higher paraffinic hydrocarbon, (c) 3 to 15% by weight of a surface-active agent, (d) 30 to 65% by weight of purified water, (e) not more than 20% by weight of a monohydric higher alcohol, (f) not more than 20% by weight of a dihdyric or trihydric alcohol, and (g) a pharmaceutically acceptable acid in an amount required to adjust the pH of the cream to a value in the range of 3.5 to 6.5 when it is diluted with water to 20 times its volume.
Inventor(s): Takashima; Yasuji (Saitama, JP), Tanaka; Shigeo (Saitama, JP), Tsunoda; Kenji (Saitama, JP), Kawamata; Ichirou (Saitama, JP), Murayama; Hiroshi (Tokyo, JP)
Assignee: Taisho Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:06/902,002
Patent Claim Types:
see list of patent claims
Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan58-14302Jan 31, 1983

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria389448► Subscribe
AustriaA31484► Subscribe
Belgium898796► Subscribe
Canada1207668► Subscribe
Switzerland662274► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fuji
Deloitte
Boehringer Ingelheim
Covington
Citi
Novartis
Mallinckrodt
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot